Clarida Technologies have announced its donation of €1.1 million worth of its advanced data discovery software to The Institute of Cancer Research in London.
Robin Poelmans, CEO and founder of Clarida Technologies said: “Besides our corporate mission of becoming a major provider worldwide of advanced data discovery software products and services to a wide variety of organisations, we find it incredibly important to deploy our software to aid in tackling some of the hardest to solve problems faced by humanity.
“Having personally witnessed the effects of cancer on patients, their family and friends I am very pleased to finalize this donation in the hope that our software can play a vital role in uncovering previously unknown new insights leading to improved cancer treatments.”
Dr. Bissan Al-Lazikani, Head of Data Science at The Institute of Cancer Research, London, said: “Modern cancer research needs more and more analysis of huge amounts of complex data. Data science therefore plays a key role in our work to discover new cancer drugs at the ICR. We’re grateful to Clarida Technologies for their generous donation and are now exploring how we can best use the software in our mission to make the discoveries that will defeat cancer.”
Clarida Technologies Ltd. offers out-of-box available advanced data-discovery software that enables users to deeply analyse large volumes of structured as well as unstructured high dimensional data at unparalleled speeds.
The software can be used by non-technical users paving the way towards making advanced analytics available to every organisation without the need to attract an in-house team of data-scientists.